Regulation 3 The Genetically Modified Organisms (Deliberate Release) Regulations (Northern Ireland) 2003I1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

omit the definition of “the Contained Use Directive”;

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

in the definition of “the First Simplified Procedure (crop plants) Decision” insert at the end “ as it applies immediately before exit day ”.

omit the words from “, in the format” to “Directive,”;

at the end, insert “ , in the relevant format set out in the Annex to Council Decision 2002/813/EC ”.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

for sub-paragraphs (b) and (c) substitute—

“(b)

genetically modified organisms are made available for activities regulated under the Genetically Modified Organisms (Contained Use) Regulations Northern Ireland 2015 M2;”;

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

omit sub paragraph (c);

in sub-paragraph (f), omit the words from “and any comments made” to the end.

in paragraph (3), omit “and to the Commission”;

for paragraph (6) substitute—

“(6)

Information submitted in accordance with paragraph (5) shall be provided in the format set out in the Annex to Commission Decision 2003/701/EC.”.

in paragraph (3)—

after paragraph (3) insert—

“(3A)

Subject to paragraph (4) and to the information not being confidential, in relation to an application for a consent under Article 8(1) of the Order to market genetically modified organisms—

(a)

the name and address of the person who is responsible for the marketing, whether manufacturer, importer or distributor,

(b)

the proposed commercial name of the product,

(c)

the names of the genetically modified organisms in the product, including the scientific and common names of, where appropriate, the parental, recipient and donor organisms,

(d)

the unique identifiers of the genetically modified organisms in the product,

(e)

an application reference code assigned by the Department,

(f)

the information included in the application as specified at paragraphs 3 and 7 of Schedule 3,

(g)

information about stored samples of genetically modified organisms, including the type of material, its genetic characterisation and stability, the amount of repository material and the conditions of appropriate storage and shelf-life.”;

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

in paragraph 2, omit “ in the European Union”;

in paragraph 5, omit “within the European Union”;

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

in paragraph 8, omit “established in the European Union”; and

in paragraph 14, for “the European Union” substitute “ Northern Ireland ”.